Archive | April, 2010

A Responsibility to Leverage the Leadership and Investments of NIH

Despite understandably varied opinions on the US federal government, I think that most of us can agree that U.S. National Institute of Health (NIH) has done remarkable things for the world and life sciences. They are the world driver and biggest supporter of genetic research, they largely funded the $3B Human Genome Project, and ...

Gene patents on trial II

Following an earlier post, the ruling by the federal judge 0n the BRCA patents held by Myriad has created a firestorm of controversy in the blogs and in the popular media. Check this out!: NPR: Gene Ruling Could Have Wide Implications 60 Minutes: Gene Patents The industry blog Genetic Future has sponsored an ...

Perhaps the Biggest (Unintended) Consequence to the Health Care Bill

The most thoughtful folks in the health care industry acknowledge that the future will be defined by molecular (aka personalized) medicine. Without being infinitely tedious, it will be a matter of measuring your body's instructions (DNA) and your present state (RNA/proteins) and prescribing a course of treatment with the most likely positive outcome and ...

Industry confusing “Cloud” with “Infrastructure”

Earlier I blogged on the distinctions between Infrastructure, Platform, and Software-as-a-Service offerings. The message was that "cloud" is an overloaded word and takes many forms and has different customer value propositions. A recent commentary in GenomeWeb "Considering a Cloud? Cost isn't everything..." citing the paper "The Real Cost of a CPU Hour" ...